Are you Dr. McKeever?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
# 2
Ann Arbor, MI 48109Phone+1 800-862-7284
Summary
- Dr. Paul McKeever, MD is a board certified pathologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan, California, and South Carolina. He is affiliated with University of Michigan Medical Center and is a Professor at University of Michigan Medical School.
Education & Training
Medical University of South CarolinaResidency, Pathology-Anatomic and Clinical, 1973 - 1976
University of California (San Diego) Medical CenterInternship, Transitional Year, 1972 - 1973
University of California, Davis, School of MedicineClass of 1972
Certifications & Licensure
MI State Medical License 1984 - 2027
CA State Medical License 1973 - 2024
SC State Medical License Active through 1979- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 11 citationsCombined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.Yoshie Umemura, Daniel Orringer, Larry Junck, Maria L Varela, Molly E J West
The Lancet. Oncology. 2023-09-01 - 2 citationsWhole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib.Dongyun Zhang, William Yong, Masoud Movassaghi, Fausto J Rodriguez, Issac Yang
Biomedicines. 2022-11-08 - 1 citationsClinical Reasoning: A 59-Year-Old Man With Progressive Proximal Weakness Since Childhood.Long Davalos, Jacqueline Janecek, Yelena Fudym, Paul E. McKeever, Brian C. Callaghan
Neurology. 2021-07-14
Press Mentions
Gene Therapy for Brain Tumor Shows Promising Early Results in HumansAugust 31st, 2023
